Chiltern is a clinical contract research organization (CRO) with experience in the management of Phase I-IV clinical trials across a range of therapeutic areas, functional service provision and contract staffing solutions.
Pasma said having already cultivated positive relationships with clients and colleagues in the region, they look forward to expanding their operations in Netherlands to further serve the clients’ needs.
Chiltern Global Country Management executive director Armand Czaplinski said Chiltern’s expansion in the Netherlands aligns perfectly with their primary goal to deliver expert, quality services around the world and demonstrates their ongoing commitment to regional expansion in order to serve the clients’ needs globally.